Artiva Biotherapeutics, Inc. (ARTV)

SEC filing

Artiva Biotherapeutics, Inc.

ARTV · CIK 1817241

4 · Aug 19, 2026 · Chief Medical Officer Banerjee Subhashis sold 429 shares at $12.00/share ($5,148); exercised options for 858 shares

Chief Medical Officer Banerjee Subhashis sold 429 shares at $12.00/share ($5,148); exercised options for 858 shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).